Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-015650
Date:2021-04-13
Issuer: KYMERA THERAPEUTICS, INC. (KYMR)
Original Submission Date:

Reporting Person:

JACOBS BRUCE N.
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN, MA 02472

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-04-13 M 7,000 a $2.08 7,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.08 2021-04-13 deemed execution date M 7,000 (d) 2029-08-28 common stock 7,000 $2.08 229,899 direct
Footnotes
IDfootnote
f1 twenty-five percent (25%) of the shares underlying this stock option vested on july 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.
WhaleWisdom Logo

Elevate your investments